Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · see citing works

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484 · see citing works

Extended-Connectivity Fingerprints

Rogers, D. O. W., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,597 · see citing works

The new frontier of genome engineering with CRISPR-Cas9

Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062 · see citing works

Network pharmacology: the next paradigm in drug discovery

Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622 · see citing works

Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay

Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261 · see citing works

LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters

Wolber, G., & Langer, T. (2004) · Journal of Chemical Information and Modeling · doi:10.1021/ci049885e · Cited by 1,989 · see citing works

The ChEMBL bioactivity database: an update

Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J. K., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,487 · see citing works

Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework

Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4309 · Cited by 1,347 · see citing works

Concepts and applications of molecular similarity

Johnson, M. A., & Maggiora, G. M. (1990) · Wiley eBooks · Cited by 1,322 · see citing works

Designed Multiple Ligands. An Emerging Drug Discovery Paradigm

Morphy, R., & Ranković, Z. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058225d · Cited by 1,237 · see citing works

Tracking cancer drugs in living cells by thermal profiling of the proteome

Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., et al. (2014) · Science · doi:10.1126/science.1255784 · Cited by 1,187 · see citing works

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155 · see citing works

Multi-target-Directed Ligands To Combat Neurodegenerative Diseases

Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152 · see citing works

Polypharmacology: Challenges and Opportunities in Drug Discovery: Miniperspective

Anighoro, A., Bajorath, J., & Rastelli, G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006463 · Cited by 1,131 · see citing works

Target identification using drug affinity responsive target stability (DARTS)

Lomenick, B., Hao, R., Jonai, N., Chin, R., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gómez, F., Loo, J. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910040106 · Cited by 1,113 · see citing works

Multi-target therapeutics: when the whole is greater than the sum of the parts

Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105 · see citing works

Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity

Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A. G., Desai, P. V., Pravenec, M., Qi, N., Wang, J., Avery, M. A., & Kurtz, T. W. (2004) · Hypertension · doi:10.1161/01.hyp.0000123072.34629.57 · Cited by 1,076 · see citing works

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Böesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,036 · see citing works

Pharmacophore modeling and applications in drug discovery: challenges and recent advances

Yang, S. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.03.013 · Cited by 902 · see citing works

Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery

Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 882 · see citing works

The promise and peril of chemical probes

Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1867 · Cited by 839 · see citing works

Automated design of ligands to polypharmacological profiles

Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832 · see citing works

Do Structurally Similar Molecules Have Similar Biological Activity?

Martin, Y. C., Kofron, J. L., & Traphagen, L. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020155c · Cited by 806 · see citing works

Antibody-drug conjugates: recent advances in conjugation and linker chemistries

Tsuchikama, K., & An, Z. (2016) · Protein & Cell · doi:10.1007/s13238-016-0323-0 · Cited by 792 · see citing works

From magic bullets to designed multiple ligands

Morphy, R., Kay, C., & Ranković, Z. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03163-0 · Cited by 731 · see citing works

A perspective on multi‐target drug discovery and design for complex diseases

Ramsay, R. R., Popović-Nikolić, M. R., Nikolic, K. M., Uliassi, E., & Bolognesi, M. L. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0181-2 · Cited by 722 · see citing works

The pharmacology of statins

Sirtori, C. R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.03.002 · Cited by 705 · see citing works

Principles in the design of ligand-targeted cancer therapeutics and imaging agents

Srinivasarao, M., Galliford, C. V., & Low, P. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4519 · Cited by 676 · see citing works

PubChem BioAssay: 2017 update

Wang, Y., Bryant, S. H., Cheng, T., Wang, J., Gindulytė, A., Shoemaker, B. A., Thiessen, P. A., He, S., & Zhang, J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1118 · Cited by 675 · see citing works

Targeting the cancer kinome through polypharmacology

Knight, Z. A., Lin, H., & Shokat, K. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2787 · Cited by 674 · see citing works

Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry

Franken, H., Mathieson, T., Childs, D., Sweetman, G. M. A., Werner, T., Tögel, I., Doce, C., Gade, S., Bantscheff, M., Drewes, G., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2015.101 · Cited by 663 · see citing works

DeepSynergy: predicting anti-cancer drug synergy with Deep Learning

Preuer, K., Lewis, R. P. I., Hochreiter, S., Bender, A., Bulusu, K. C., & Klambauer, G. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx806 · Cited by 651 · see citing works

Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity

Dubowchik, G. M., Firestone, R. A., Padilla, L., Willner, D., Hofstead, S. J., Mosure, K. W., Knipe, J. O., Lasch, S. J., & Trail, P. A. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025536j · Cited by 560 · see citing works

High-throughput crystallography for lead discovery in drug design

Blundell, T. L., Jhoti, H., & Abell, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd706 · Cited by 529 · see citing works

Shifting from the single to the multitarget paradigm in drug discovery

Medina‐Franco, J. L., Giulianotti, M. A., Welmaker, G. S., & Houghten, R. A. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.01.008 · Cited by 486 · see citing works

Polypharmacology – Foe or Friend?

Peters, J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400856t · Cited by 477 · see citing works

Can we rationally design promiscuous drugs?

HOPKINS, A., MASON, J., & OVERINGTON, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.013 · Cited by 469 · see citing works

Target Identification for Small Bioactive Molecules: Finding the Needle in the Haystack

Ziegler, S., Pries, V., Hedberg, C., & Waldmann, H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208749 · Cited by 466 · see citing works

Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases

Apsel, B., Blair, J. A., González, B., Nazif, T. M., Feldman, M. E., Aizenstein, B., Hoffman, R., Williams, R. L., Shokat, K. M., & Knight, Z. A. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.117 · Cited by 452 · see citing works

Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective

Talevi, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00205 · Cited by 397 · see citing works

Prospects for new antibiotics: a molecule-centered perspective

Walsh, C. T., & Wencewicz, T. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.49 · Cited by 373 · see citing works

<i>De Novo</i> Design of Bioactive Small Molecules by Artificial Intelligence

Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373 · see citing works

Natural compounds and combination therapy in colorectal cancer treatment

Rejhova, A., Opattová, A., Čumová, A., Slíva, D., & Vodička, P. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.12.039 · Cited by 367 · see citing works

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

Ciceri, P., Müller, S., O’Mahony, A., Fedorov, O., Filippakopoulos, P., Hunt, J. P., Lasater, E. A., Pallares, G., Picaud, S., Wells, C. D., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1471 · Cited by 345 · see citing works

Chemical genetic discovery of targets and anti-targets for cancer polypharmacology

Dar, A. C., Das, T. K., Shokat, K. M., & Cagan, R. L. (2012) · Nature · doi:10.1038/nature11127 · Cited by 334 · see citing works

Dual or multi-targeting inhibitors: The next generation anticancer agents

Raghavendra, N. M., Pingili, D., Kadasi, S., Mettu, A., & Prasad, S. V. U. M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.021 · Cited by 333 · see citing works

Drug repositioning and repurposing: terminology and definitions in literature

Langedijk, J., Mantel-Teeuwisse, A. K., Slijkerman, D. S., & Schutjens, M.-H. D. B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.001 · Cited by 327 · see citing works

Designing Smart Polymer Conjugates for Controlled Release of Payloads

Seidi, F., Jenjob, R., & Crespy, D. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00006 · Cited by 320 · see citing works

Molecule-pharmacophore superpositioning and pattern matching in computational drug design

Wolber, G., Seidel, T., Bendix, F., & Langer, T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.09.007 · Cited by 315 · see citing works

Multi-targeting by monotherapeutic antibacterials

Silver, L. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 312 · see citing works

Thermal proteome profiling monitors ligand interactions with cellular membrane proteins

Reinhard, F. B. M., Eberhard, D., Werner, T., Franken, H., Childs, D., Doce, C., Savitski, M. F., Huber, W. K., Bantscheff, M., Savitski, M. M., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3652 · Cited by 310 · see citing works

In silico repositioning of approved drugs for rare and neglected diseases

Ekins, S., Williams, A. J., Krasowski, M. D., & Freundlich, J. S. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.016 · Cited by 288 · see citing works

From in silico target prediction to multi-target drug design: Current databases, methods and applications

Koutsoukas, A., Simms, B., Kirchmair, J., Bond, P. J., Whitmore, A. V., Zimmer, S., Young, M. P., Jenkins, J. L., Glick, M., Glen, R. C., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.011 · Cited by 287 · see citing works

NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning

Chen, X., Ren, B., Chen, M., Wang, Q., Zhang, L., & Yan, G. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004975 · Cited by 281 · see citing works

A history of antipsychotic drug development

Shen, W. W. (1999) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(99)90082-2 · Cited by 279 · see citing works

Designing multi-targeted agents: An emerging anticancer drug discovery paradigm

Fu, R.-G., Sun, Y., Sheng, W., & Liao, D. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.05.016 · Cited by 264 · see citing works

Designing Multiple Ligands – Medicinal Chemistry Strategies and Challenges

Morphy, R., & Ranković, Z. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315594 · Cited by 262 · see citing works

Multi-Target Drugs: The Trend of Drug Research and Development

Lu, J., Pan, W., Yuanjia, H., & Wang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040262 · Cited by 259 · see citing works

Cancer biomarkers: selecting the right drug for the right patient

Kelloff, G. J., & Sigman, C. C. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3651 · Cited by 253 · see citing works

DOGS: Reaction-Driven de novo Design of Bioactive Compounds

Hartenfeller, M., Zettl, H., Walter, M., Rupp, M., Reisen, F., Proschak, E., Weggen, S., Stark, H., & Schneider, G. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002380 · Cited by 251 · see citing works

Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature

Poornima, P., Kumar, J. D., Zhao, Q., Blunder, M., & Efferth, T. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.018 · Cited by 250 · see citing works

Sideromycins: tools and antibiotics

Braun, V., Pramanik, A., Gwinner, T., Köberle, M., & Bohn, E. (2009) · BioMetals · doi:10.1007/s10534-008-9199-7 · Cited by 237 · see citing works

Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis

Krause, M., Zhu, Y., Huhn, M., Schneider‐Thoma, J., Bighelli, I., Nikolakopoulou, A., & Leucht, S. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0869-3 · Cited by 234 · see citing works

Methods for High-throughput Drug Combination Screening and Synergy Scoring

He, L., Kulesskiy, E., Saarela, J., Turunen, L., Wennerberg, K., Aittokallio, T., & Tang, J. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7493-1_17 · Cited by 232 · see citing works

In silico methods to address polypharmacology: current status, applications and future perspectives

Lavecchia, A., & Cerchia, C. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.12.007 · Cited by 228 · see citing works

Multifunctional compounds: Smart molecules for multifactorial diseases

Bansal, Y., & Silakari, O. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.01.060 · Cited by 215 · see citing works

Comparative Assessment of Scoring Functions on an Updated Benchmark: 1. Compilation of the Test Set

Li, Y., Liu, Z., Li, J., Han, L., Liu, J., Zhao, Z., & Wang, R. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500080q · Cited by 214 · see citing works

Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms

Kleinstreuer, N. C., Yang, J., Berg, E. L., Knudsen, T. B., Richard, A. M., Martin, M. T., Reif, D. M., Judson, R. S., Polokoff, M., Dix, D. J., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2914 · Cited by 211 · see citing works

Fragments, network biology and designing multiple ligands

Morphy, R., & Ranković, Z. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.12.006 · Cited by 204 · see citing works

Selective Optimization of Side Activities: Another Way for Drug Discovery

Wermuth, C. G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030480f · Cited by 202 · see citing works

The Physicochemical Challenges of Designing Multiple Ligands

Morphy, R., & Ranković, Z. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0603015 · Cited by 194 · see citing works

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome

Vitale, C., Mercuro, G. G., Castiglioni, C., Cornoldi, A., Tulli, A., Fini, M., Volterrani, M., & Rosano, G. M. C. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-6 · Cited by 193 · see citing works

Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy

Lee, J. A., Uhlik, M. T., Moxham, C. M., Tomandl, D., & Sall, D. J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201649s · Cited by 190 · see citing works

Computational Multitarget Drug Design

Zhang, W., Pei, J., & Lai, L. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00491 · Cited by 186 · see citing works

Development and Properties of β-Glucuronide Linkers for Monoclonal Antibody−Drug Conjugates

Jeffrey, S. C., Andreyka, J. B., Bernhardt, S. X., Kissler, K. M., Kline, T. B., Lenox, J. S., Moser, R. F., Nguyen, M. T., Okeley, N. M., Stone, I. J., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0600214 · Cited by 183 · see citing works

Modeling Parkinson's Disease in Primates: The MPTP ModelPreprint

Porras, G., Li, Q., & Bézard, E. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009308 · Cited by 180 · see citing works

Pharmacophore-Based Virtual Screening

Sun, H. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784049630 · Cited by 176 · see citing works

Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease

Dias, K. S. T., & Viegas, C. (2014) · Current Neuropharmacology · doi:10.2174/1570159x1203140511153200 · Cited by 174 · see citing works

Structural Protein?Ligand Interaction Fingerprints (SPLIF) for Structure-Based Virtual Screening: Method and Benchmark Study

Da, C., & Kireev, D. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500319f · Cited by 172 · see citing works

De Novo Design at the Edge of Chaos

Schneider, P., & Schneider, G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01849 · Cited by 167 · see citing works

Chemically Advanced Template Search (CATS) for Scaffold‐Hopping and Prospective Target Prediction for ‘Orphan’ Molecules

Reutlinger, M., Koch, C. P., Reker, D., et al. (2013) · Molecular Informatics · doi:10.1002/minf.201200141 · Cited by 166 · see citing works

How to design multi-target drugs

Korcsmaros, T. D., Szalay, M., Böde, C., Kovács, I. A., & Csermely, P. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.6.799 · Cited by 162 · see citing works

De Novo Drug Design

Hartenfeller, M., & Schneider, G. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-839-3_12 · Cited by 160 · see citing works

A Synthetic Dual Drug Sideromycin Induces Gram-Negative Bacteria To Commit Suicide with a Gram-Positive Antibiotic

Liu, R., Miller, P. A., Vakulenko, S. B., Stewart, N. K., Boggess, B., & Miller, M. J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00218 · Cited by 153 · see citing works

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease

Unzeta, M., Esteban, G., Bolea, I., Fogel, W. A., Ramsay, R. R., Youdim, M. B. H., Tipton, K. F., & Marco, J. L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00205 · Cited by 151 · see citing works

Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent

Artis, D. R., Lin, J. J., Zhang, C., Wang, W., Mehra, U., Perreault, M., Erbe, D. V., Krupka, H. I., England, B. P., Arnold, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811325106 · Cited by 150 · see citing works

Hybrid Compounds as Direct Multitarget Ligands: A Review

Pedrosa, M. O., da Cruz, R. M. D., Viana, J. D. O., et al. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160927160620 · Cited by 150 · see citing works

Epigenetic polypharmacology: from combination therapy to multitargeted drugs

de Lera, Á. R., & Ganesan, A. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0271-9 · Cited by 148 · see citing works

Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease

Wang, L., Esteban, G., Ojima, M., Bautista‐Aguilera, Ó. M., Inokuchi, T., Moraleda, I., Iriepa, I., Samadi, A., Youdim, M. B. H., Romero, A., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.078 · Cited by 143 · see citing works

Discovery of Multitarget Inhibitors by Combining Molecular Docking with Common Pharmacophore Matching

Wei, D., Jiang, X., Zhou, L., Chen, J., Chen, Z., He, C., Yang, K., Liu, Y., Pei, J., & Lai, L. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8010096 · Cited by 141 · see citing works

Identification and structure elucidation of the pro‐resolving mediators provides novel leads for resolution pharmacology

Dalli, J., & Serhan, C. N. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14336 · Cited by 138 · see citing works

Inhibitors of the Arachidonic Acid Cascade: Interfering with Multiple Pathways

Meirer, K., Steinhilber, D., & Proschak, E. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12134 · Cited by 137 · see citing works

Liver-specific drug targeting by coupling to bile acids.

Kramer, W., Wess, G., Schubert, G., et al. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37003-6 · Cited by 134 · see citing works

Targeted Antibiotic Delivery: Selective Siderophore Conjugation with Daptomycin Confers Potent Activity against Multidrug Resistant Acinetobacter baumannii Both in Vitro and in Vivo

Ghosh, M., Miller, P. A., Möllmann, U., Claypool, W. D., Schroeder, V. A., Wolter, W. R., Suckow, M. A., Yu, H., Li, S., Huang, W., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00102 · Cited by 134 · see citing works

Trihydroxamate Siderophore–Fluoroquinolone Conjugates Are Selective Sideromycin Antibiotics that Target Staphylococcus aureus

Wencewicz, T. A., Long, T. E., Möllmann, U., & Miller, M. J. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300610f · Cited by 132 · see citing works

Biscatecholate–Monohydroxamate Mixed Ligand Siderophore–Carbacephalosporin Conjugates are Selective Sideromycin Antibiotics that Target Acinetobacter baumannii

Wencewicz, T. A., & Miller, M. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400265k · Cited by 128 · see citing works

Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles

Li, X., Xu, Y., Cui, H. S., Huang, T., Wang, D., Lian, B., Li, W., Qin, G., Chen, L., & Xie, L. (2017) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2017.05.008 · Cited by 127 · see citing works

Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity

Tuplin, E. W. N., & Holahan, M. R. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170413115754 · Cited by 124 · see citing works

Dynamic tuneable G protein-coupled receptor monomer-dimer populations

Dijkman, P. M., Castell, O. K., Goddard, A. D., Muñoz-García, J. C., de Graaf, C., Wallace, M. I., & Watts, A. G. (2018) · Nature Communications · doi:10.1038/s41467-018-03727-6 · Cited by 121 · see citing works

Harnessing synthetic lethality to predict the response to cancer treatment

Lee, J. S., Das, A., Jerby‐Arnon, L., Arafeh, R., Auslander, N., Davidson, M. A., McGarry, L., James, D. T., Amzallag, A., Park, S. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04647-1 · Cited by 120 · see citing works

Memoquin: A Multi-Target–Directed Ligand as an Innovative Therapeutic Opportunity for Alzheimer's Disease

Bolognesi, M. L., Cavalli, A., & Melchiorre, C. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.042 · Cited by 117 · see citing works

Comparative Analysis of Pharmacophore Screening Tools

Sanders, M. P. A., Barbosa, A. J. M., Zarzycka, B. A., Nicolaes, G. A. F., Klomp, J. P. G., de Vlieg, J., & Río, A. D. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci2005274 · Cited by 117 · see citing works

The role of fragment-based and computational methods in polypharmacology

Bottegoni, G., Favia, A. D., Recanatini, M., & Cavalli, A. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.08.002 · Cited by 116 · see citing works

Dynamic Simulations on the Arachidonic Acid Metabolic Network

Yang, K., Ma, W., Liang, H., Ouyang, Q., Tang, C., & Lai, L. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030055 · Cited by 115 · see citing works

Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception

Naidu, P. S., Booker, L., Cravatt, B. F., & Lichtman, A. H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143487 · Cited by 114 · see citing works

Strategies for modern biomarker and drug development in oncology

Smith, A. D., Roda, D., & Yap, T. A. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0070-8 · Cited by 111 · see citing works

Hitting multiple targets with multimeric ligands

Handl, H. L., Vágner, J., Han, H., Mash, E. A., Hruby, V. J., & Gillies, R. J. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.565 · Cited by 111 · see citing works

Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer’s Disease

Prati, F., Cavalli, A., & Bolognesi, M. (2016) · Molecules · doi:10.3390/molecules21040466 · Cited by 110 · see citing works

Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies

Kurtz, S. E., Eide, C. A., Kaempf, A. J., Khanna, V., Savage, S. L., Rofelty, A., English, I. A., Ho, H., Pandya, R., Bolosky, W. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703094114 · Cited by 109 · see citing works

Drug discovery and development for rare genetic disorders

Sun, W., Zheng, W., & Simeonov, A. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38326 · Cited by 107 · see citing works

Statins: the new aspirin?

Veillard, N. R., & Mach, F. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012505 · Cited by 106 · see citing works

Hot-Spots-Guided Receptor-Based Pharmacophores (HS-Pharm): A Knowledge-Based Approach to Identify Ligand-Anchoring Atoms in Protein Cavities and Prioritize Structure-Based Pharmacophores

Barillari, C., Marcou, G., & Rognan, D. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800064z · Cited by 106 · see citing works

Multitarget‐Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H₃R Antagonism for Neurodegenerative Diseases

Bautista‐Aguilera, Ó. M., Hagenow, S., Palomino‐Antolin, A., Farré‐Alins, V., Ismaili, L., Joffrin, P., Jimeno, M. L., Soukup, O., Janočková, J., Kalinowsky, L., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201706072 · Cited by 105 · see citing works

Profiling Bioactivity of the ToxCast Chemical Library Using BioMAP Primary Human Cell Systems

Houck, K., Dix, D., Judson, R., Kavlock, R., Yang, J., & Berg, E. (2009) · Journal of biomolecular screening · doi:10.1177/1087057109345525 · Cited by 101 · see citing works

The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses

Tschinke, V., & Cohen, N. C. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00076a016 · Cited by 97 · see citing works

A Computational Approach for Identifying Synergistic Drug Combinations

Gayvert, K. M., Aly, O., Platt, J. T., Bosenberg, M., Stern, D. F., & Elemento, O. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005308 · Cited by 97 · see citing works

Polypharmacology in Precision Oncology: Current Applications and Future Prospects

Antolín, A. A., Workman, P., Mestres, J., & Al‐Lazikani, B. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160923115828 · Cited by 96 · see citing works

High-Throughput Crystallography: Reliable and Efficient Identification of Fragment Hits

Schiebel, J., Krimmer, S. G., Röwer, K., et al. (2016) · Structure · doi:10.1016/j.str.2016.06.010 · Cited by 94 · see citing works

Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry

Fronik, P., Gaiser, B. I., & Pedersen, D. S. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01601 · Cited by 94 · see citing works

Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery

Ravikumar, B., & Aittokallio, T. A. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1413089 · Cited by 93 · see citing works

Rationally Designed Multi-Targeted Agents Against Neurodegenerative Diseases

Geldenhuys, W. J., & der Schyf, C. J. V. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990112 · Cited by 92 · see citing works

One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug

Hughes, R. E., Nikolic, K. M., & Ramsay, R. R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00177 · Cited by 92 · see citing works

Orthosteric/Allosteric Bitopic Ligands: Going Hybrid at GPCRs

Valant, C., Sexton, P. M., & Christopoulos, A. (2009) · Molecular Interventions · doi:10.1124/mi.9.3.6 · Cited by 91 · see citing works

Kinase-likeness and Kinase-Privileged Fragments: Toward Virtual Polypharmacology

Aronov, A. M., McClain, B., Moody, C. S., & Murcko, M. A. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701021b · Cited by 91 · see citing works

Multitarget drugs: the present and the future of cancer therapy

Petrelli, A., & Valabrega, G. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902781907 · Cited by 90 · see citing works

3-Benzisothiazolylpiperazine Derivatives as Potential Atypical Antipsychotic Agents

Howard, H. R., Lowe, J. A., III, Seeger, T., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950625l · Cited by 90 · see citing works

5-HT1 and 5-HT2: binding characteristics of some quipazine analogs

Glennon, R. A., Slusher, R. M., Lyon, R. A., et al. (1986) · Journal of Medicinal Chemistry · doi:10.1021/jm00161a038 · Cited by 89 · see citing works

Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery

Proschak, E., Heitel, P., Kalinowsky, L., & Merk, D. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01287 · Cited by 89 · see citing works

Cefiderocol: a novel siderophore cephalosporin

Choi, J. J., & McCarthy, M. W. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1426745 · Cited by 88 · see citing works

A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis

Schmidt, J., Rotter, M., Weiser, T., Wittmann, S. K., Weizel, L., Kaiser, A., Heering, J., Goebel, T., Angioni, C., Wurglics, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00398 · Cited by 87 · see citing works

Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets

Miller, M. L., Molinelli, E. J., Nair, J. S., Sheikh, T., Samy, R., Jing, X., He, Q., Korkut, A., Crago, A. M., Singer, S., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004014 · Cited by 86 · see citing works

In defence of polypharmacy

Aronson, J. K. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02067.x · Cited by 85 · see citing works

Experimental Models of Parkinson's Disease: From the Static to the Dynamic

Bézard, E., Imbert, C., & Gross, C. E. (1998) · Reviews in the Neurosciences · doi:10.1515/revneuro.1998.9.2.71 · Cited by 83 · see citing works

Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction

Varjabedian, L., Bourji, M., Pourafkari, L., & Nader, N. D. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-0266-3 · Cited by 83 · see citing works

Multivalent Ligand: Design Principle for Targeted Therapeutic Delivery Approach

Chittasupho, C. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.99 · Cited by 81 · see citing works

Dual Aromatase−Steroid Sulfatase Inhibitors

Woo, L. W. L., Bubert, C., Sutcliffe, O. B., Smith, A., Chander, S. K., Mahon, M. F., Purohit, A., Reed, M. J., & Potter, B. V. L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061462b · Cited by 80 · see citing works

Quantification of Pathway Cross-talk Reveals Novel Synergistic Drug Combinations for Breast Cancer

Jaeger, S., Igea, A., Arroyo, R., Alcalde, V., Cánovas, B., Orozco, M., Nebreda, Á. R., & Aloy, P. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0097 · Cited by 77 · see citing works

The use of natural compounds for the targeting and chemoprevention of ovarian cancer

Pistollato, F., Iglesias, R. C., Ruíz, R., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.050 · Cited by 76 · see citing works

The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action

Wong, E. H. F., Tarazi, F. I., & Shahid, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.001 · Cited by 75 · see citing works

Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation

Castañeda, L., Maruani, A., Schumacher, F. F., Miranda, E., Chudasama, V., Chester, K. A., Baker, J. R., Smith, M. E. B., & Caddick, S. (2013) · Chemical Communications · doi:10.1039/c3cc45220d · Cited by 75 · see citing works

Predicting Drug Combination Index and Simulating the Network-Regulation Dynamics by Mathematical Modeling of Drug-Targeted EGFR-ERK Signaling Pathway

Huang, L., Jiang, Y., & Chen, Y. (2017) · Scientific Reports · doi:10.1038/srep40752 · Cited by 75 · see citing works

Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration

Ramsay, R. R., Májeková, M., Medina, M., & Valoti, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00375 · Cited by 74 · see citing works

Drug Repurposing and the Medicinal Chemist

Aubé, J. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300114c · Cited by 73 · see citing works

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis

Zumla, A. I., Rao, M., Dodoo, E., & Maeurer, M. J. (2016) · BMC Medicine · doi:10.1186/s12916-016-0635-1 · Cited by 73 · see citing works

Target Fishing for Chemical Compounds Using Target-Ligand Activity Data and Ranking Based Methods

Wale, N., & Karypis, G. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci9000376 · Cited by 70 · see citing works

Development of a New Class of Nonimidazole Histamine H3 Receptor Ligands with Combined Inhibitory Histamine N-Methyltransferase Activity

Apelt, J., Ligneau, X., Pertz, H. H., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0110845 · Cited by 69 · see citing works

Designed Multiple Ligands: Basic Research vs Clinical Outcomes

Costantino, L., & Barlocco, D. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801215883 · Cited by 69 · see citing works

3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer’s Disease

Prati, F., Simone, A. D., Armirotti, A., Summa, M., Pizzirani, D., Scarpelli, R., Bertozzi, S. M., Pérez, D. I., Andrisano, V., Pérez‐Castillo, A., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00121 · Cited by 68 · see citing works

De Novo Design of Multitarget Ligands with an Iterative Fragment-Growing Strategy

Shang, E., Yuan, Y., Chen, X., Liu, Y., Pei, J., & Lai, L. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500021v · Cited by 68 · see citing works

Polypharmacology of dopamine receptor ligands

Butini, S., Nikolic, K. M., Kassel, S., Brückmann, H., Filipić, S., Agbaba, D. D., Gemma, S., Brogi, S., Brindisi, M., Campiani, G., et al. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.011 · Cited by 67 · see citing works

Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles

Dolles, D., Hoffmann, M., Gunesch, S., Marinelli, O., Möller, J., Santoni, G., Chatonnet, A., Lohse, M. J., Wittmann, H.-J., Strasser, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01760 · Cited by 67 · see citing works

Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth

Al‐Ali, H., Lee, D.-H., Danzi, M. C., Nassif, H., Gautam, P., Wennerberg, K., Zuercher, B., Drewry, D. H., Lee, J. K., Lemmon, V., et al. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00289 · Cited by 65 · see citing works

Designed Multiple Ligands: An Emerging Anti-HIV Drug Discovery Paradigm

Zhan, P., & Liu, X. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788453266 · Cited by 64 · see citing works

Targets Looking for Drugs: A Multistep Computational Protocol for the Development of Structure-Based Pharmacophores and Their Applications for Hit Discovery

Tintori, C., Corradi, V., Magnani, M., et al. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800105p · Cited by 64 · see citing works

Aromatase and Dual Aromatase‐Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates

Wood, P. M., Woo, L. W. L., THOMAS, M. P., Mahon, M. F., Purohit, A., & Potter, B. V. L. (2011) · ChemMedChem · doi:10.1002/cmdc.201100145 · Cited by 64 · see citing works

Multitarget ligands in antibacterial research: progress and opportunities

East, S. P., & Silver, L. L. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.743991 · Cited by 64 · see citing works

New Insights Into the Anti-Diabetic Actions of Metformin: From the Liver to the Gut

Wu, T., Horowitz, M., & Rayner, C. K. (2017) · Expert Review of Gastroenterology &amp; Hepatology · doi:10.1080/17474124.2017.1273769 · Cited by 64 · see citing works

Serotonin, β‐amyloid, and cognition in Parkinson disease

Kotagal, V., Spino, C., Bohnen, N. I., Koeppe, R., & Albin, R. L. (2018) · Annals of Neurology · doi:10.1002/ana.25236 · Cited by 64 · see citing works

High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance

Wambaugh, M. A., Shakya, V. P. S., Lewis, A. J., Mulvey, M. A., & Brown, J. C. S. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2001644 · Cited by 63 · see citing works

A whole-animal platform to advance a clinical kinase inhibitor into new disease space

Sonoshita, M., Scopton, A. P., Ung, P. M. U., Murray, M. A., Silber, L., Maldonado, A. Y., Real, A. M., Schlessinger, A., Cagan, R. L., & Dar, A. C. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2556 · Cited by 63 · see citing works

Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats

Imig, J. D., Walsh, K., Khan, A. H., Nagasawa, T., Shaw, M. C., Shaw, S. M., & Hammock, B. D. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012225 · Cited by 60 · see citing works

The story of antipsychotics: Past and present

Ramachandraiah, C., Subramaniam, N., & Tancer, M. E. (2009) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.58304 · Cited by 60 · see citing works

Serendipity in Cancer Drug Discovery: Rational or Coincidence?

Prasad, S., Gupta, S. C., & Aggarwal, B. B. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.03.004 · Cited by 59 · see citing works

The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network Perspective

Li, Y., Wang, P., Li, X. X., Yu, C. Y., Yang, H. J., Zhou, J., Xue, W., Tan, J., & Zhu, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165737 · Cited by 59 · see citing works

Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs

Tao, L., Zhu, F., Xu, F., Chen, Z., Jiang, Y., & Chen, Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.09.019 · Cited by 56 · see citing works

Small molecules with anti-inflammatory properties in clinical development

Hanke, T., Merk, D., Steinhilber, D., Geißlinger, G., & Schubert‐Zsilavecz, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.011 · Cited by 54 · see citing works

Discovery of a Series of Imidazo[4,5-b]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ

Casimiro‐Garcia, A., Filzen, G. F., Flynn, D. A., Bigge, C. F., Chen, J., Davis, J. A., Dudley, D. A., Edmunds, J. J., Esmaeil, N., Geyer, A. G., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200409s · Cited by 53 · see citing works

1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents

Lowe, J. A., III, Seeger, T., Nagel, A. A., et al. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00110a016 · Cited by 53 · see citing works

N -Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators

Blöcher, R., Lamers, C., Wittmann, S. K., Merk, D., Hartmann, M., Weizel, L., Diehl, O., Brüggerhoff, A., Boß, M., Kaiser, A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01239 · Cited by 53 · see citing works

Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders

Bawa, P., Pradeep, P., Kumar, P., Choonara, Y. E., Modi, G., & Pillay, V. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.08.001 · Cited by 53 · see citing works

High-content screening of small compounds on human embryonic stem cells.

Barbaric, I., Gokhale, P., & Andrews, P. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381046 · Cited by 52 · see citing works

The pleiotropic functions of aspirin: mechanisms of action

Amin, A. R., Attur, M. G., Pillinger, M. H., et al. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050432 · Cited by 51 · see citing works

An Innovative Strategy for Dual Inhibitor Design and Its Application in Dual Inhibition of Human Thymidylate Synthase and Dihydrofolate Reductase Enzymes

Arooj, M., Sakkiah, S., Cao, G. P., & Lee, K. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060470 · Cited by 51 · see citing works

Dual-Target Virtual Screening by Pharmacophore Elucidation and Molecular Shape Filtering

Moser, D. M., Wisniewska, J. M., Hahn, S., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200286e · Cited by 50 · see citing works

Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure

Mason, D. J., Stott, I. P., Ashenden, S. K., Weinstein, Z., Karakoc, I., Meral, S., Kuru, N., Bender, A., & Cokol, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00204 · Cited by 50 · see citing works

Advances in computational approaches in identifying synergistic drug combinations

Sheng, Z., Sun, Y., Yin, Z., Tang, K., & Cao, Z. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx047 · Cited by 50 · see citing works

Effects of Aspirin on Endothelial Function and Hypertension

Dzeshka, M. S., Shantsila, A., & Lip, G. Y. H. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0688-8 · Cited by 47 · see citing works

Experimental animal models of Parkinson's disease: A transition from assessing symptomatology to α-synuclein targeted disease modification

Ko, W. K. D., & Bézard, E. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.020 · Cited by 47 · see citing works

Serotonergic Approaches in Parkinson's Disease: Translational Perspectives, an Update.

Huot, P., Sgambato-Faure, V., Fox, S., & McCreary, A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00440 · Cited by 46 · see citing works

Synthesis of bile acid - drug conjugates: Potential drug - shuttles for liver specific targeting

Wess, G., Kramer, W., Schubert, G., et al. (1993) · Tetrahedron Letters · doi:10.1016/0040-4039(93)89021-h · Cited by 45 · see citing works

Accessing target information by virtual parallel screening—The impact on natural product research

Rollinger, J. M. (2008) · Phytochemistry Letters · doi:10.1016/j.phytol.2008.12.002 · Cited by 45 · see citing works

Fragment‐Based Discovery of a Dual pan‐RET/VEGFR2 Kinase Inhibitor Optimized for Single‐Agent Polypharmacology

Frett, B., Carlomagno, F., Moccia, M. L., Brescia, A., Federico, G., Falco, V. D., Admire, B., Chen, Z., Qi, W., Santoro, M. M., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201501104 · Cited by 45 · see citing works

Network Analysis of Drug–target Interactions: A Study on FDA-approved New Molecular Entities Between 2000 to 2015

Lin, H.-H., Zhang, L., Yan, R., Lu, J., & Yuanjia, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-12061-8 · Cited by 45 · see citing works

ADME and Safety Aspects of Non-cleavable Linkers in Drug Discovery and Development

Walles, M., Connor, A., & Hainzl, D. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180118153502 · Cited by 45 · see citing works

The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates

Frigerio, M., & Kyle, A. F. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180118155847 · Cited by 44 · see citing works

A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes

Khan, A. H., Kolb, L. L., Skibba, M. E., Hartmann, M., Blöcher, R., Proschak, E., & Imig, J. D. (2018) · Diabetologia · doi:10.1007/s00125-018-4685-0 · Cited by 44 · see citing works

Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network

He, C., Wu, Y., Lai, Y., Cai, Z., Liu, Y., & Lai, L. (2012) · Molecular BioSystems · doi:10.1039/c2mb05503a · Cited by 43 · see citing works

Characterization of New PPARγ Agonists: Analysis of Telmisartan’s Structural Components

Goebel, M., Clemenz, M., Staels, B., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200800285 · Cited by 43 · see citing works

A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance

Hu, H., Zhao, X., Kaushik, S., Robillard, L., Barthelet, A., Lin, K., Shah, K. N., Simmons, A. D., Raponi, M., Harding, T. C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.093 · Cited by 42 · see citing works

A novel interaction fingerprint derived from per atom score contributions: exhaustive evaluation of interaction fingerprint performance in docking based virtual screening

Jasper, J., Humbeck, L., Brinkjost, T., & Koch, O. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0264-0 · Cited by 42 · see citing works

Use of biomarkers in ALS drug development and clinical trials

Bakkar, N., Boehringer, A. V., & Bowser, R. P. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.031 · Cited by 41 · see citing works

Leveraging Large-scale Behavioral Profiling in Zebrafish to Explore Neuroactive Polypharmacology

McCarroll, M. N., Gendelev, L., Keiser, M. J., & Kokel, D. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00800 · Cited by 41 · see citing works

The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats

Khan, N., Saad, A. K., Nurulain, S. M., Darras, F. H., Decker, M. W., & Sadek, B. S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.10.022 · Cited by 40 · see citing works

Targeting Epigenetic Networks with Polypharmacology: A New Avenue to Tackle Cancer

Franci, G., Miceli, M., & Altucci, L. (2010) · Epigenomics · doi:10.2217/epi.10.62 · Cited by 39 · see citing works

Telmisartan Improves Insulin Resistance: A Meta-Analysis

Wang, Y., Qiao, S., De-wu, H., et al. (2018) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000733 · Cited by 39 · see citing works

Exploring the Chemical Space of Multitarget Ligands Using Aligned Self-Organizing Maps

Achenbach, J., Klingler, F., Blöcher, R., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4002562 · Cited by 38 · see citing works

Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity

Woo, L. W. L., Bubert, C., Purohit, A., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100273k · Cited by 38 · see citing works

Predicting synergistic effects between compounds through their structural similarity and effects on transcriptomes

Liu, Y., & Zhao, H. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw509 · Cited by 38 · see citing works

Targeting Protein Multiple Conformations: A Structure-Based Strategy for Kinase Drug Design

Jeffrey, L., & Robert, A. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607781696783 · Cited by 37 · see citing works

Artificial intelligence to deep learning: machine intelligence approach for drug discovery

Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473 · see citing works

A Perspective on Multi-target Drugs for Alzheimer’s Disease

Benek, O., Korabecny, J., & Soukup, O. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.04.008 · Cited by 260 · see citing works

From combinations to multitarget-directed ligands: A continuum in Alzheimer’s disease polypharmacology

Albertini, C., Salerno, A., de Sena Murteira Pinheiro, P., & Bolognesi, M. L. (2021) · Medicinal Research Reviews · doi:10.1002/med.21699 · Cited by 179 · see citing works

Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?: Miniperspective

De Simone, A., Tumiatti, V., Andrisano, V., & Milelli, A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00931 · Cited by 110 · see citing works

Enhancing autophagy in Alzheimer's disease through drug repositioning

Eshraghi, M., Ahmadi, M., Afshar, S., Lorzadeh, S., Adlimoghaddam, A., Rezvani Jalal, N., West, R., Dastghaib, S., Igder, S., Torshizi, S. R. N., et al. (2022) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2022.108171 · Cited by 89 · see citing works

Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy

Tan, L., Zhang, J., Wang, Y., Wang, X., Wang, Y., Zhang, Z., Shuai, W., Wang, G., Chen, J., Wang, C., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01714 · Cited by 88 · see citing works

A community challenge for a pancancer drug mechanism of action inference from perturbational profile data

Douglass, E. F., Allaway, R. J., Szalai, B., Wang, W., Tian, T., Fernández-Torras, A., Realubit, R., Karan, C., Zheng, S., Pessia, A., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100492 · Cited by 68 · see citing works

Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects <i>In Vitro</i> and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model

He, F., Chou, C. J., Scheiner, M., Poeta, E., Yuan Chen, N., Gunesch, S., Hoffmann, M., Sotriffer, C., Monti, B., Maurice, T., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01940 · Cited by 66 · see citing works

Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo

Scheiner, M., Dolles, D., Gunesch, S., Hoffmann, M., Nabissi, M., Marinelli, O., Naldi, M., Bartolini, M., Petralla, S., Poeta, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00623 · Cited by 49 · see citing works

Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer’s disease

Jiang, X., Zhou, J., Wang, Y., Chen, L., Duan, Y., Huang, J., Liu, C., Chen, Y., Liu, W., Sun, H., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112751 · Cited by 39 · see citing works

Multitarget PPARγ Agonists as Innovative Modulators of the Metabolic Syndrome

Ammazzalorso, A., Maccallini, C., Amoia, P., & Amoroso, R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.04.030 · Cited by 39 · see citing works

Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo

Stern, N., Gacs, A., Tátrai, E., Flachner, B., Hajdú, I., Dobi, K., Bágyi, I., Dormán, G., Lőrincz, Z., Cseh, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113098 · Cited by 35 · see citing works

Design and structural optimization of dual FXR/PPARδ activators

Schierle, S., Neumann, S., Heitel, P., Willems, S., Kaiser, A., Pollinger, J., & Merk, D. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00618 · Cited by 34 · see citing works

Development of new Alzheimer’s disease drug candidates using donepezil as a key model

Eissa, K. I., Kamel, M. M., Mohamed, L. W., & Kassab, A. E. (2023) · Archiv der Pharmazie · doi:10.1002/ardp.202200398 · Cited by 20 · see citing works

Are there environments that help cultivate serendipity?Preprint

Nguyen, M. (2022) · doi:10.31219/osf.io/tzqga

The process of serendipity in knowledge work

McCay‐Peet, L., & Toms, E. G. (2010) · Information Interaction in Context Symposium (IIiX) · doi:10.1145/1840784.1840842 · Cited by 81 · see citing works

Repositioning Natural Products in Drug Discovery

Rastelli, G., Pellati, F., Pinzi, L., & Gamberini, M. C. (2020) · Molecules · doi:10.3390/molecules25051154 · Cited by 47 · see citing works

Drug combination therapy increases successful drug repositioning

Sun, W., Sanderson, P. E. J., & Zheng, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.015 · Cited by 438 · see citing works

In Silico Drug Design Methods for Drug Repurposing

Akhoon, B. A., Tiwari, H., & Nargotra, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00003-1 · Cited by 30 · see citing works